GENETYPE
LIVE

Serial Number

79264799

Owner

Genetic Technologies Limited

Attorney

Charles G. Zug

Filing Date

Mar 6, 2019

Add to watchlist:

No watchlists yet
View on USPTO

GENETYPE Trademark

Serial Number: 79264799 • Registration: 6291484

GENETYPE is a trademark filed by Genetic Technologies Limited on March 6, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Genetic Technologies Limited (8 trademarks)

60-66 Hanover Street

Entity Type: 99

RHY Genetype Pty Ltd

'BlO21 Molecular Science & Biotechnology lnstitute

Entity Type: 98

Trademark Details

Filing Date

March 6, 2019

Registration Date

March 16, 2021

Published for Opposition

December 29, 2020

Goods & Services

Pharmaceutical and veterinary preparations for the treatment of a wide variety of diseases, and diagnostic kits consisting primarily of primers, probes, buffers, and reagents for use in genetic testing for medical purposes; diagnostic preparations and reagents for medical use; diagnostic test kits comprised primarily of reagents and assays for medical use

Diagnostic preparations and reagents for scientific use; diagnostic preparations and reagents for scientific laboratory use; diagnostic test kits comprised primarily of reagents and assays for scientific use

Apparatus and instruments, namely, DNA genotyping arrays, DNA sequencing instruments, computer hardware, recorded computer programs, and downloadable software all featuring proprietary algorithms to analyse DNA; scientific and teaching apparatus and instruments, namely, downloadable electronic publications in the nature of books, pamphlets, brochures, newsletters, journals, magazines and periodicals in the field of risk assessment testing; recorded computer software and downloadable computer software to analyse and record the results of DNA testing; equipment to analyse and record the results of DNA testing, namely, laboratory devices for detecting genetic and protein substances, DNA genotyping arrays, DNA sequencing instruments, and recorded software for scientific analysis of genetic and protein sequences, assessment kits comprised primarily of laboratory swabs and also containing bar-coded specimen envelope, instruction sheet, specimen information form, and pre-paid mailing envelope

Medical diagnostic services, namely, reagent sample testing and diagnostic services for others in the fields of [ science and ] medical research; genetic testing for medical purposes, namely, genome mapping, genome analysis, and genome scanning; provision of medical services, veterinary services [, genetic testing for medical purposes and forensic biological screening of DNA for medical purposes ] ; providing medical diagnostic services and veterinary diagnostic services

Biotechnology research and development services for others, including genetic association studies, genome mapping, genome analysis and genome scanning, pharmaceutical drug and therapeutics development; product development, including consumer health product development and consultation in the field of genomics and pharmaceutical drug development; provision of scientific and medical research in the fields of DNA typing and profiling; computer programming services for DNA typing and profiling for use in medical research * ; genetic testing for medical purposes and forensic biological screening of DNA for medical purposes *

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 16, 2026 REM3
CHANGE OF OWNER RECEIVED FROM IB
Feb 21, 2025 CHLD
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Apr 26, 2022 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 12, 2021 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 16, 2021 FICS
FINAL DISPOSITION PROCESSED
Jun 16, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 16, 2021 FICR
LIMITATION FROM THE IB EXAMINED AND ENTERED
Apr 12, 2021 LIME
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 12, 2021 APRE
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 12, 2021 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 12, 2021 APRE
REGISTERED-PRINCIPAL REGISTER
Mar 16, 2021 R.PR
LIMITATION OF GOODS RECEIVED FROM IB
Feb 28, 2021 LIMG
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 30, 2021 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 13, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 13, 2021 OPNR
NOTIFICATION PROCESSED BY IB
Jan 10, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 29, 2020 NPUB
PUBLISHED FOR OPPOSITION
Dec 29, 2020 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 23, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 23, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 9, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 10, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 10, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 10, 2020 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 2, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jun 2, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jun 2, 2020 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
May 1, 2020 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Mar 31, 2020 PBCR
ASSIGNED TO LIE
Mar 19, 2020 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 14, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 12, 2020 TROA
REFUSAL PROCESSED BY IB
Sep 28, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 12, 2019 RFCS
REFUSAL PROCESSED BY MPU
Sep 12, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sep 3, 2019 RFCR
NON-FINAL ACTION WRITTEN
Sep 2, 2019 CNRT
NON-FINAL ACTION WRITTEN
Sep 2, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Aug 21, 2019 MAFR
ASSIGNED TO EXAMINER
Aug 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 17, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 8, 2019 REPR